期刊文献+

丙型肝炎病毒血清学检测的方法学评价 被引量:1

Methodological Evaluation of the Serological Detection of Hepatitis C Virus
下载PDF
导出
摘要 目的比较酶联免疫吸附试验(ELISA)、化学发光微粒子免疫检测法(CMIA)、PCR-荧光探针法三种方法对同一种样本检测结果的一致性。方法 120例疑似丙型肝炎患者的血清标本同时用ELISA与CMIA检测HCV-Ab,PCR-荧光探针法检测HCV-RNA。结果在不考虑CMIA检测HCV-Ab结果为可疑的情况下,ELISA与CMIA检测HCV-Ab结果具有一致性。当CMIA检测HCV-Ab结果为可疑时,ELISA检测HCV-Ab的OD值与CMIA检测HCV-Ab的S/CO值没有相关性。当CMIA检测HCV-Ab结果为阳性时,ELISA检测HCV-Ab的OD值与PCR-荧光探针法检测HCV-RNA的含量没有相关性,CMIA检测HCV-Ab的S/CO值与PCR-荧光探针法检测HCV-RNA的含量也没有相关性。结论在临床检测丙型肝炎病毒感染时建议采用化学发光微粒子免疫检测法(CMIA)检测HCV-Ab的同时也采用PCR-荧光探针法检测HCV-RNA含量,这样不仅可以降低漏诊,同时也为临床抗病毒提供有效的医学数据。由于ELISA检测HCV-Ab仍然具有可靠性,对于基层医院,ELISA检测HCV-Ab仍是首选的方法。 Objective To compare the consistency on the results of the same samples determined by ELISA, CMIA and PCR-fluorescent-probe. Methods The HCV-Ab of 120 serum samples obtained from patients with suspected HCV was detected by ELISA and CMIA, and the HCV-RNA was detected by PCR-fluorescent-probe. Results When the results detected by CMIA were not considered suspiciously, results of the ELISA and CMIA in detection HCV-Ab were consistent. There was no correlation between the ELISA test HCV-Ab OD values and HCV-Ab S/CO values of CMIA, when the HCV-Ab results detected by CMIA were suspicious. However, when results detected by CMIA were positive, there was no correlation between the ELISA OD values and the RNA content of the HCV by PCR-fluorescence-probe, at the same time, there was no correlation between CMIA S/CO values and HCV-RNA content detected by PCR-fluoreseence probe, either. Conclusions In screening HCV infection clinically, we suggest applying CMIA plus PCR-fluorescence-probe methods. Thus not only the misdiagnosis will be reduced, but also more clinical effective antiviral medical data will be provided. ELISA remains the preferred method in detecting HCV-Ab in loacl hospitals, as it still has a high reliability.
出处 《临床医学工程》 2012年第5期706-708,共3页 Clinical Medicine & Engineering
关键词 HCV-AB HCV-RNA 酶联免疫吸附试验 化学发光微粒子免疫检测法 PCR-荧光探针法 HCV-Ab HCV-RNA ELISA CMIA PCR-fluorescence-probe
  • 相关文献

参考文献2

二级参考文献22

  • 1文汉成,安社刚,张红芳.抗-HCV与HCV-RNA检测结果不一致原因分析[J].实用医技杂志,2004,11(09A):1707-1708. 被引量:8
  • 2潘克女,张永乐,任绪义,陈刚,刘宝根.定量聚合酶链反应在丙型肝炎病毒感染检测中的应用及临床意义[J].浙江临床医学,2006,8(11):1213-1213. 被引量:7
  • 3Coppola N, Pisapia R, Marrocco C, et al. Anti-HCV IgG avidity index in acute hepatitis C. J Clin Virol, 2007,40:110-115.
  • 4Liaw YF, Tsai SL, Sheen IS, et al. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers. Am J Gastroenterol, 1998,93:354-359.
  • 5Carreno V, Bartolome J, Castillo I, et al. Occult hepatitis B virus and hepatitis C virus infections.Rev Med Virol, 2008,18:139-157.
  • 6Drebber U, Kasper HU, Krupacz J, et al. The role of Epstein-Barr virus in acute and chronic hepatitis. J Hepatol, 2006,44:879-885.
  • 7Levitsky J, Singh N, Wagener MM, et al. A survey of CMV prevention strategies after liver transplantation. Am J Transplant, 2008,8: 158-161.
  • 8Matthews GV, Dore GJ. HIV and hepatitis C coinfection. J Gastroenterol Hepatol, 2008,23:1000-1008.
  • 9Ferri C. Mixed cryoglobulinemia. Orphanet. J Rare Dis, 2008,3:25.
  • 10Ferri S, Muratori L, Lenzi M, et al. HCV and autoimmunity. Curr Pharm Des, 2008,14:1678-1685.

共引文献18

同被引文献42

  • 1廖远泉.PIVKA-Ⅱ检验诊断肝细胞癌的临床应用(日文译文)[J].临床检验杂志(电子版),2012,1(2):116-118. 被引量:5
  • 2廖远泉.丙型肝炎病毒感染致病机制的研究进展[J].临床检验杂志(电子版),2012,1(4):216-220. 被引量:3
  • 3姚仁南,陈复兴,陈玲,蔡信海,王永方,陈娜云,赵飞.应用化学发光免疫分析法检测HCV抗体与其他方法的比较[J].临床输血与检验,2011,13(3):200-202. 被引量:4
  • 4魏来,管文莉,饶慧瑛,杜绍财,祁自柏,任英蓉.丙型肝炎病毒抗体诊断试剂盒(EIAgen HCV Ab Kit)的可信度分析[J].检验医学,2006,21(B10):2-7. 被引量:3
  • 5Gale Mjr, Foy EM. Evasion of intracellular host defence by hepatitis C virus [ J ]. Nature,2005,436 ( 18 ) :939 - 945.
  • 6Hezode C, Forestier N, Dusheiko G, et al. Telaprevir and peginterferon withoutribavirin for chronic HCV infection [ J ]. N Engl J Med,2009 ,360( 30 ) :1839 - 1850.
  • 7Irshad M, Dhar I, Hepatitis C virus core protein an update on its molecular biology. Cellular functions and clinical implications [J]. Med Princ Pract ,2006 ,15 ( 6 ) :405 -416.
  • 8Moratorio G, Martinez M, Gutierrez MF, et al. Evolution of naturally occurring 5' non-coding region variants of hepatitis C virus in human populations of the South American region [ J ]. Virol J,2007,4( 1 ) :79 -85.
  • 9Alter MJ, Kuhnert WL, Finelli L, et al. Guidelines for laboratory, testing and result reporting of antibody to hepatitis C vints Centers for Disease Control and Prevention [ J ]. MMWR RecommRep ,2003,52 ( RR-3 ) : 1 - 13,15.
  • 10Bowser CS, Kaye J, Leier TU, et al. Prevalence of viral and fnycobacterial co-infections in perinatally HIV-infected children [ J ]. Fetal Pediatr Pathol,2006,25 (6) : 321 - 331.

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部